Table 8 |
||
|
Association between OP-1 and other growth factors including igf-1, insulin, and tyrosine-kinase signaling |
||
|
rhOP-1 vs Cntr |
OP-1AS vs Cntr |
|
|
fold change |
fold change |
|
|
|
||
|
IGF-BP1 |
2.17↓ |
|
|
Nerve growth factor-β |
1.93↓ |
|
|
VEGF-β |
1.62↓ |
1.50↓ |
|
Endothelial cell growth factor 1 (platelet-derived) |
1.56↓ |
|
|
VEGF |
1.52↓ |
|
|
Capillary morphogenesis protein 1 |
1.52↓ |
|
|
FGF-7 |
2.87↓ |
|
|
FGF-R2 |
1.69↑ |
2.83↓ |
|
IGF-BP5 |
1.90↓ |
|
|
FGF-R3 |
1.87↑ |
1.80↓ |
|
IGF-1R |
1.73↓ |
|
|
PDGF-Rα |
1.62↑ |
1.70↓ |
|
PDGF-Rβ |
1.68↓ |
|
|
IGF-BP7 |
1.58↓ |
|
|
IRS2 (insulin receptor substrate 2) |
2.10↓ |
1.70↑ |
|
DPYSL2 (dihydropyrimidinase-like 2) |
1.60↑ |
1.60↓ |
|
MET (hepatocyte growth factor receptor) |
1.70↓ |
1.60↑ |
|
SPRY2: sprouty homolog 2 (Drosophila) |
1.60↓ |
1.60↑ |
|
SORBS1: sorbin and SH3 domain containing 1 |
1.70↑ |
1.50↓ |
|
PIK3R1 (Phosphoinositide-3-kinase, regulatory subunit 1) |
1.72↑ |
|
|
MAP2K2 (mitogen-activated protein kinase kinase 2) |
1.61↑ |
|
|
PDE3B (phosphodiesterase 3B, cGMP-inhibited) |
2.00↑ |
|
|
SOCS3 (suppressor of cytokine signaling 3) |
1.79↑ |
|
|
|
||
|
Chubinskaya et al. Arthritis Research & Therapy 2011 13:R55 doi:10.1186/ar3300 |
||